Jones Day advised Axion Biosystems, Inc., while White & Case advised Summa Equity on the deal. Summa Equity Fund II (“Summa”) has acquired a majority stake…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
